Transformational merger brings together Telix’s commercial precision medicine platform with ITM’s scaled radioisotope ...

Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, ...

Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final ...

US healthtech company Massive Bio has appointed international business development consultancy Intralink to support its ...

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease ...

Expanded Unique Dual Index range enables high-throughput laboratories to quadruple multiplexing capacity while retaining ...

Pixclara® is the first FDA-approved FET-PET imaging drug for glioma (brain cancer). Approval addresses a significant unmet ...

Next-generation anti-IgE monoclonal antibody becomes the first biologic candidate in China to file a BLA for seasonal ...

Preliminary MAGMAP trial results in 62 patients show a 96% sentinel node identification rate and no false negatives in the ...

Blood-brain barrier-penetrating therapy targets MPS IIIB, an ultra-rare lysosomal storage disorder with no currently approved ...

New stackable chambers provide precise environmental control, remote monitoring and data logging for pharmaceutical, biotech, ...

Combination brings single-cell and spatial transcriptomics together with GLP/GCLP-compliant qPCR and bioanalytical ...